查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1972098

牙科黏合剂市场：按类型、应用、最终用户和分销管道划分 - 2026 年至 2032 年全球预测

Dental Bonding Agent Market by Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，牙科黏合剂市场价值将达到 186.5 亿美元，到 2026 年将成长至 203.1 亿美元，到 2032 年将达到 340 亿美元，复合年增长率为 8.95%。

主要市场统计数据
基准年 2025 186.5亿美元
预计年份：2026年 203.1亿美元
预测年份：2032年 340亿美元
复合年增长率 (%) 8.95

详细介绍牙科黏合剂，将临床性能、材料创新、监管影响和商业性动态联繫起来，以便做出明智的决策。

牙科黏合剂是现代黏合牙科的基础，它能使修復材料与牙齿组织牢固黏接，从而改善美观、提高耐久性和治疗效率。在过去十年间，为了应对临床医生操作差异、牙齿对水分的敏感性以及对微创治疗的需求，黏合剂的化学成分不断发展，最终形成了一系列适用于不同临床工作流程的黏合系统。这些产品融合了临床实践、材料科学和法律规范，其选择直接影响修復效果、患者满意度以及后续维护的需求。

临床重点、先进化学技术、不断发展的修復工作流程以及不断变化的经销模式如何重塑牙科黏合剂的模式？

牙科黏合剂市场正经历一场变革，其驱动力来自临床需求的融合、材料科学的突破以及不断演变的分销模式。临床上，人们对简化的通讯协定和提高在潮湿、污染牙本质等严苛操作条件下的耐受性有着强烈的需求，这推动了耐受性更佳的黏合剂化学成分的应用。同时，数位化修復工作流程的整合以及CAD/CAM材料的日益普及，也催生了对能够可靠黏接于多种间接基材的黏合剂的需求，进一步增加了对通用型、不依赖于基材的配方的需求。

了解美国关税趋势对整个牙科黏合剂价值链的累积影响，包括供应链、价格压力和筹资策略。

近期主要经济体的贸易政策趋势和关税措施正在加强对整体医疗和牙科耗材供应链的监控。美国在2025年之前可能实施的关税措施，可能会对牙科黏合剂领域的成本结构、筹资策略和采购方式产生累积影响。关税相关的成本压力可能会增加依赖跨境供应单体、引发剂、填料和特殊包装材料的製造商的到岸投入成本。因此，一些生产商可能会选择实现供应链的地域多元化、确保上游库存，或将部分生产流程转移到低关税地区，以维持利润率和价格竞争力。

将产品化学、临床应用、终端用户需求和分销管道进行策略性细分，对于推动有针对性的开发和商业化至关重要。

了解细分市场对于产品开发、临床定位和市场进入策略至关重要，因为每个细分维度都涵盖了不同的临床应用情境和商业性管道。按类型划分，市面上的黏合剂可分为双固化型、光固化型和自固化型，每种化学成分都体现了操作时间、固化深度以及对特定间接或即时修復应用的适用性方面的权衡。这种差异会影响研发优先顺序以及产品声明在监理申报中的验证方式。按应用划分，黏合剂可分为直接修復和间接修復。直接修復类别又可细分为I类和II类修復以及III类和IV类修復，以反映咬合面和美学方面的要求。另一方面，间接修復类别则专注于陶瓷和复合树脂修復，其中与黏合通讯协定和表面处理的兼容性至关重要。

美洲、欧洲、中东和非洲以及亚太地区的区域趋势和策略考量影响着监管、采购和采用结果，因此地理洞察对于市场策略至关重要。

地理洞察对市场策略至关重要，因为区域趋势深刻影响监管管道、采购趋势和临床应用模式。在美洲，临床医生网路和机构采购系统往往优先考虑实证产品选择和高效的供应物流。同时，需求形成涉及个别医生购买和大规模联合采购组织的多种模式。区域报销框架和临床指南也会影响产品应用，尤其是在同时评估成本效益和临床疗效时。

如何透过临床证据、互补的生态系统、强大的分销网络以及针对当地社区和最终用户的策略参与来建立竞争优势。

黏合剂领域的竞争格局由技术差异化、产品线广度以及提供端到端临床支援和供应可靠性的能力共同决定。领先参与企业往往专注于累积可靠的临床证据、建立策略通路伙伴关係，并投资于针对医疗专业人员的专项培训项目，以降低对技术的依赖性，并在实际应用环境中展现产品的长期性能。此外，企业也增加对生产品质系统和法规遵循的投入，以确保不同地区产品品质的一致性。

製造商和相关人员可采取的实际策略行动，以增强产品稳健性、供应链韧性、证据产生和区域定向商业化。

针对行业领导者的具体建议着重于使产品开发、监管规划和商业性实施与现代临床工作流程和采购实际情况相符。首先，应优先考虑降低技术依赖性并增强基材相容性的配方策略，以应对日常实践中遇到的各种直接和间接修復场景。投资通用黏合剂的化学研发和清晰的临床通讯协定，将有助于增强临床医生的信心，并简化牙科诊所和实验室的库存需求。

为了提供实际的见解，我们采用严格的三角测量调查方法，结合临床访谈、实验室检验、监管审查和商业环境分析。

本分析的调查方法整合了多方面的证据，在确保分析严谨性的同时，也兼顾了实务应用的平衡性。研究首先对临床医生、牙科技师、采购经理和分销专员进行了结构化访谈，以了解实际使用模式、面临的挑战和决策标准。此外，研究还仔细审查了实验室检验测试和同行评审的临床文献，以评估配製材料的性能特征，例如黏接耐久性、耐湿性和与修復基质的相容性。这些技术评估结果与临床实践的回馈相结合，使实验室指标与临床意义相符。

将材料创新、临床应用、供应链韧性和客製化商业化相结合，从而在修復牙科领域创造永续价值，这是一种具有前瞻性的整合。

总之，牙科黏合剂仍然是修復牙科中至关重要的组成部分，其临床和商业性价值受到黏合剂化学技术进步、修復工作流程演变以及分销模式发展的影响。该领域正朝着简化临床通讯协定和扩大基材相容性的配方方向发展，并辅以有针对性的临床证据和从业人员培训计划。供应链的韧性、法规遵循和通路策略也对产品在医院、诊所和实验室的应用起着决定性作用。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 牙科黏合剂市场：按类型划分

  • 双固化型
  • 光固化型
  • 自固化型

第九章 牙科黏合剂市场：依应用领域划分

  • 直接修復
    • 第一类和第二类
    • 三/四级
  • 间接修復
    • 陶瓷修復
    • 复合树脂修復

第十章 牙科黏合剂市场：依最终用户划分

  • 牙科医院和牙科诊所
  • 牙科实验室

第十一章 牙科黏合剂市场：依分销管道划分

  • 医院药房
  • 线上销售
  • 零售药房

第十二章 牙科黏合剂市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 牙科黏合剂市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 牙科黏合剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国牙科黏合剂市场

第十六章：中国牙科黏合剂市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • BISCO, Inc.
  • COLTENE Holding AG
  • Cosmedent, Inc.
  • Dentsply Sirona Inc.
  • DETAX GmbH
  • DiaDent Group International Inc.
  • DMG Chemisch-Pharmazeutische Fabrik GmbH
  • Essential Dental Systems, Inc.
  • FGM Dental Group
  • GC Corporation
  • Hoffmann Dental Manufaktur GmbH
  • Ivoclar Vivadent AG
  • Kerr Corporation
  • Kuraray Noritake Dental Inc.
  • Medental International, Inc.
  • Medicinos linija UAB
  • NuSmile Ltd.
  • Shofu Dental Corporation
  • Tokuyama Dental Corporation
  • VOCO GmbH
Product Code: MRR-2B5802CFEB4F

The Dental Bonding Agent Market was valued at USD 18.65 billion in 2025 and is projected to grow to USD 20.31 billion in 2026, with a CAGR of 8.95%, reaching USD 34.00 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 18.65 billion
Estimated Year [2026] USD 20.31 billion
Forecast Year [2032] USD 34.00 billion
CAGR (%) 8.95%

An in-depth orientation to dental bonding agents that connects clinical performance, material innovations, regulatory influences, and commercial dynamics for informed decision-making

Dental bonding agents form the foundation of modern adhesive dentistry by enabling strong adhesion between restorative materials and tooth tissues while enhancing aesthetics, longevity, and procedural efficiency. Over the past decade, material chemistries have evolved to address operator variability, moisture sensitivity, and the demand for minimally invasive interventions, resulting in a portfolio of adhesive systems tailored for diverse clinical workflows. These products intersect clinical practice, materials science, and regulatory frameworks, and their selection affects restorative outcomes, patient satisfaction, and downstream maintenance needs.

Clinicians evaluate bonding agents not only for immediate bond strength but also for durability under cyclic loading, resistance to hydrolytic degradation, and compatibility with both direct composite systems and indirect restorative substrates. Concurrently, manufacturers invest in formulation improvements that simplify application steps and reduce technique sensitivity. From a commercial perspective, distribution dynamics, reimbursement policies, and digital dentistry adoption shape product access and purchasing decisions. Therefore, understanding bonding agent performance requires integrating lab-based evidence, clinical trial outcomes, and real-world adoption patterns.

This introduction sets the scene for a nuanced examination of the sector, emphasizing clinical utility, manufacturing innovation, and the market forces that drive product development and procurement. It positions readers to appreciate how incremental material advances and shifting delivery channels combine to influence clinical practice and strategic planning across dental care providers and laboratory partners.

How clinical priorities, advanced chemistries, evolving restorative workflows, and shifting distribution paradigms are reshaping the dental bonding agent landscape

The landscape for dental bonding agents is undergoing transformative shifts driven by converging clinical priorities, material science breakthroughs, and evolving distribution models. Clinically, there is a strong emphasis on simplifying protocols and improving tolerance to challenging operative conditions such as moisture and contaminated dentin, which has spurred adoption of more forgiving adhesive chemistries. At the same time, the integration of digital restorative workflows and increased use of CAD/CAM materials have created demand for adhesives that reliably bond to varied indirect substrates, reinforcing the need for universal and substrate-agnostic formulations.

On the manufacturing front, novel polymer chemistries, nanofiller technologies, and improved coupling agents are extending adhesive durability and esthetic stability, while sustainability considerations are prompting reassessment of packaging and solvent systems. Distribution channels are also shifting: professional procurement increasingly balances traditional dental distribution with digital procurement platforms and direct-to-clinic supply arrangements, affecting how products reach end users. Moreover, regulatory expectations for biocompatibility and performance validation are rising, prompting companies to invest in stronger clinical evidence packages to support market access.

As a result, competitive differentiation is less about marginal improvements in bond strength and more about total value propositions that combine ease of use, evidence-backed clinical outcomes, compatibility with modern restorative workflows, and reliable supply chains. These transformative shifts require manufacturers and clinical leaders to pivot strategies toward integrated solutions that align with contemporary practice patterns and procurement realities.

Understanding the cumulative influence of evolving United States tariff dynamics on supply chains, pricing pressure, and procurement strategies across the dental bonding value chain

Recent trade policy developments and tariff measures by major economies have amplified supply chain scrutiny across medical and dental consumables, and potential tariff actions in the United States through 2025 carry cumulative implications for cost structures, sourcing strategies, and procurement practices within the dental adhesives sector. Tariff-related cost pressures can increase landed input costs for manufacturers that rely on cross-border supply of monomers, initiators, fillers, and specialized packaging. Consequently, some producers may choose to geographically diversify suppliers, secure upstream inventory, or migrate certain manufacturing steps to lower-tariff jurisdictions to preserve margin and price competitiveness.

In parallel, distributors and end users face operational impacts: procurement teams may reprioritize suppliers with more favorable trade exposure or negotiate longer-term supply agreements to mitigate volatility. Increased import costs can also incentivize vertical integration or local contract manufacturing arrangements that shorten supply chains and reduce exposure to tariff swings. From a clinical adoption standpoint, any incremental price pressure may slow the replacement cycle for premium adhesive systems in budget-constrained settings, while resilient procurement channels and group purchasing organizations can buffer price transmission.

Ultimately, the cumulative impact of tariff dynamics is less about a single event and more about accelerating strategic responses across the value chain. Companies that proactively map trade exposure, invest in supplier redundancy, and communicate transparently with clinical customers will be better positioned to sustain market access and maintain confidence among dental professionals and laboratory partners.

Strategic segmentation insights that align product chemistry, clinical application, end-user demands, and distribution pathways to inform targeted development and commercialization

Segment-level understanding is essential for product development, clinical positioning, and go-to-market strategy because each axis of segmentation captures distinct clinical use-cases and commercial pathways. Based on Type, the market differentiates among Dual Cure, Light Cure, and Self Cure formulations, with each chemistry offering trade-offs in working time, depth of cure, and suitability for specific indirect or immediate restorative applications. This variation informs R&D prioritization and affects how product claims are substantiated in regulatory filings. Based on Application, bonding solutions are studied across Direct Restorations and Indirect Restorations; the Direct Restorations category is further delineated across Class I, II and Class III, IV restorations reflecting occlusal and esthetic demands, while the Indirect Restorations category focuses on Ceramic Restorations and Composite Restorations where compatibility with luting protocols and surface treatments becomes critical.

Based on End User, product adoption and purchasing behavior diverge between Dental Hospitals And Clinics and Dental Laboratories, with hospitals and clinics prioritizing workflow efficiency and broad-spectrum performance while laboratories emphasize compatibility with laboratory-fabricated substrates and long-term interfacial stability. Finally, based on Distribution Channel, access pathways include Hospital Pharmacies, Online Sales, and Retail Pharmacies, each channel imposing different requirements for packaging, documentation, and order fulfillment timing. Together, these segmentation dimensions create a matrix of clinical and commercial considerations that should guide product portfolio optimization, evidence generation priorities, and market entry sequencing. By aligning formulation choices and messaging to the needs of each segment, manufacturers can optimize uptake and minimize adoption friction across professional and laboratory settings.

Region-specific dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape regulatory, procurement, and adoption outcomes

Regional dynamics exert a profound influence on regulatory pathways, procurement preferences, and clinical adoption patterns, making geographic insight indispensable for market strategy. In the Americas, clinician networks and institutional procurement systems frequently emphasize evidence-based product selection and efficient supply logistics, while demand is shaped by a mix of private practice purchasing and larger group purchasing organizations. Reimbursement frameworks and clinical guidelines in this region also affect product uptake, particularly where cost-effectiveness is evaluated alongside clinical performance.

Europe, Middle East & Africa presents a heterogeneous landscape with diverse regulatory environments, varying procurement capabilities, and differentiated access to laboratory infrastructure. In Western Europe, rigorous regulatory standards and strong clinical networks encourage manufacturers to provide substantial clinical validation, whereas in parts of the Middle East and Africa, distribution resilience and localized training initiatives can be decisive for adoption. Supply chain considerations and local partnership models often determine market entry success across these subregions.

Asia-Pacific encompasses a wide spectrum of healthcare systems, from highly consolidated urban centers with advanced dental laboratories and rapid technology adoption to emerging markets where price sensitivity and distribution reach are primary drivers. Rapid urbanization, growing dental service demand, and expanding private clinics in key Asia-Pacific economies create opportunities for differentiated adhesives that balance cost, ease of use, and compatibility with local restorative practices. Collectively, these regional patterns require tailored regulatory strategies, localized educational support, and channel-specific supply models to maximize commercial traction.

How competitive advantage is forged through clinical evidence, complementary ecosystems, resilient distribution, and targeted regional and end-user engagement strategies

Competitive dynamics in the bonding agent space are defined by a combination of technological differentiation, product breadth, and the ability to provide end-to-end clinical support and supply reliability. Leading players tend to invest in robust clinical evidence generation, strategic channel partnerships, and targeted training programs for practitioners to reduce technique sensitivity and demonstrate long-term performance under real-world conditions. These activities are reinforced by investment in production quality systems and regulatory compliance to ensure consistent product quality across geographies.

In addition to core adhesive formulations, companies that offer complementary consumables, application systems, and clinician education often achieve stronger account penetration because they reduce switching costs and create broader product ecosystems. Strategic alliances with dental schools, opinion leaders, and laboratory networks also accelerate adoption by generating peer-to-peer validation. Furthermore, nimble mid-size manufacturers can leverage focused innovation and customized market approaches to win niches, particularly in markets where tailored solutions for local restorative practices are valued. Operational excellence in logistics and technical support remains a key differentiator, especially where supply continuity and rapid product replenishment are critical to clinical workflows.

Overall, market leadership emerges from a blended capability set: scientifically credible products, compelling clinical support, resilient distribution, and the agility to adapt offerings to specific end-user and regional requirements. Companies that successfully integrate these elements can capture durable preference among clinicians and laboratory partners.

Practical strategic actions for manufacturers and stakeholders to strengthen product robustness, supply resilience, evidence generation, and regionally tailored commercialization

Actionable recommendations for industry leaders center on aligning product development, regulatory planning, and commercial execution with contemporary clinical workflows and procurement realities. First, prioritize formulation strategies that reduce technique sensitivity and increase substrate compatibility to address the broad spectrum of direct and indirect restorative scenarios encountered in daily practice. Investing in universal adhesive chemistries and clear clinical protocols can accelerate clinician confidence and streamline inventory requirements for dental practices and laboratories.

Second, strengthen supply chain resilience by diversifying upstream suppliers, exploring localized manufacturing partnerships, and negotiating flexible logistics arrangements to mitigate trade-related disruptions. These measures will support consistent product availability across Hospital Pharmacies, Retail Pharmacies, and Online Sales channels. Third, build compelling evidence packages that combine in vitro performance data with real-world clinical outcomes across representative restoration classes and laboratory applications; such data supports reimbursement discussions and institutional procurement decisions. Fourth, tailor go-to-market approaches by region, recognizing that Americas, Europe Middle East & Africa, and Asia-Pacific each require distinct regulatory, training, and channel strategies to maximize adoption.

Finally, invest in integrated commercial offerings that bundle adhesives with application aids, clinician training, and digital resources to lower the barriers to adoption. By focusing on these priorities-product robustness, supply resilience, evidence-based claims, regional customization, and ecosystem-level solutions-industry leaders can strengthen market positioning and drive sustainable clinical adoption.

A rigorous, triangulated research methodology combining clinical interviews, laboratory validation, regulatory reviews, and commercial landscape analysis to support actionable insights

The research methodology underpinning this analysis integrates multiple evidence streams to ensure balanced, practice-oriented insights while maintaining analytical rigor. Primary inputs include structured interviews with practicing clinicians, laboratory technicians, procurement leads, and distribution specialists to capture real-world usage patterns, pain points, and decision criteria. Laboratory validation studies and peer-reviewed clinical literature are examined to assess formulation performance characteristics such as bond durability, moisture tolerance, and compatibility with restorative substrates. These technical assessments are synthesized with field feedback to align laboratory metrics to clinical relevance.

Secondary inputs comprise regulatory documentation, product technical files, and publicly available manufacturer literature to map claim sets and compliance approaches. Competitive landscape analysis leverages corporate disclosures, product launch histories, and commercial channel mapping to identify strategic differentiators. Where appropriate, scenario analysis is used to explore the implications of trade dynamics, supply chain disruptions, and distribution shifts, emphasizing qualitative strategic implications over speculative quantitative forecasts.

Throughout the methodology, triangulation is applied to validate findings, ensuring that technical performance, clinician experience, regulatory context, and commercial realities converge to support robust insights. Transparency in source types and analytical assumptions underpins the credibility of conclusions and enables stakeholders to adapt the findings to their specific operational contexts.

A forward-looking synthesis that ties material innovation, clinical adoption, supply resilience, and tailored commercialization to durable value creation in restorative dentistry

In conclusion, dental bonding agents remain a pivotal component of restorative dentistry, with their clinical and commercial relevance shaped by advances in adhesive chemistry, changing restorative workflows, and evolving distribution models. The sector is characterized by a clear movement toward formulations that simplify clinical protocols and broaden substrate compatibility, supported by targeted clinical evidence and practitioner training programs. Supply chain resilience, regulatory compliance, and channel strategy likewise play decisive roles in how products are adopted across hospitals, clinics, and laboratories.

Strategic success will accrue to organizations that align product innovation with pragmatic clinical needs, invest in evidence generation that resonates with institutional buyers, and design distribution and support models tailored to regional and end-user realities. By combining strong technical performance with accessible training and dependable logistics, manufacturers can reduce adoption friction and build durable preference among clinicians and laboratory partners. The intersection of material science progress and strategic commercialization thus offers multiple pathways for sustained value creation and improved patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dental Bonding Agent Market, by Type

  • 8.1. Dual Cure
  • 8.2. Light Cure
  • 8.3. Self Cure

9. Dental Bonding Agent Market, by Application

  • 9.1. Direct Restorations
    • 9.1.1. Class I Ii
    • 9.1.2. Class Iii Iv
  • 9.2. Indirect Restorations
    • 9.2.1. Ceramic Restorations
    • 9.2.2. Composite Restorations

10. Dental Bonding Agent Market, by End User

  • 10.1. Dental Hospitals And Clinics
  • 10.2. Dental Laboratories

11. Dental Bonding Agent Market, by Distribution Channel

  • 11.1. Hospital Pharmacies
  • 11.2. Online Sales
  • 11.3. Retail Pharmacies

12. Dental Bonding Agent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Dental Bonding Agent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Dental Bonding Agent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Dental Bonding Agent Market

16. China Dental Bonding Agent Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. BISCO, Inc.
  • 17.7. COLTENE Holding AG
  • 17.8. Cosmedent, Inc.
  • 17.9. Dentsply Sirona Inc.
  • 17.10. DETAX GmbH
  • 17.11. DiaDent Group International Inc.
  • 17.12. DMG Chemisch-Pharmazeutische Fabrik GmbH
  • 17.13. Essential Dental Systems, Inc.
  • 17.14. FGM Dental Group
  • 17.15. GC Corporation
  • 17.16. Hoffmann Dental Manufaktur GmbH
  • 17.17. Ivoclar Vivadent AG
  • 17.18. Kerr Corporation
  • 17.19. Kuraray Noritake Dental Inc.
  • 17.20. Medental International, Inc.
  • 17.21. Medicinos linija UAB
  • 17.22. NuSmile Ltd.
  • 17.23. Shofu Dental Corporation
  • 17.24. Tokuyama Dental Corporation
  • 17.25. VOCO GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DENTAL BONDING AGENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DENTAL BONDING AGENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DUAL CURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DUAL CURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DUAL CURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY LIGHT CURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY LIGHT CURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY LIGHT CURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY SELF CURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY SELF CURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY SELF CURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS I II, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS I II, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS I II, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS III IV, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS III IV, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CLASS III IV, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CERAMIC RESTORATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CERAMIC RESTORATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY CERAMIC RESTORATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY COMPOSITE RESTORATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY COMPOSITE RESTORATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY COMPOSITE RESTORATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DENTAL LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. GCC DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 119. GCC DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 120. GCC DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. GCC DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. G7 DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 140. G7 DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 141. G7 DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. G7 DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. NATO DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NATO DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. NATO DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 147. NATO DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 148. NATO DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NATO DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL DENTAL BONDING AGENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA DENTAL BONDING AGENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA DENTAL BONDING AGENT MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA DENTAL BONDING AGENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA DENTAL BONDING AGENT MARKET SIZE, BY DIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA DENTAL BONDING AGENT MARKET SIZE, BY INDIRECT RESTORATIONS, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA DENTAL BONDING AGENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA DENTAL BONDING AGENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)